Article Details

Israeli startup CytoReason joins forces with Ferring Pharmaceuticals to find new IBD treatment

Retrieved on: 2021-05-19 07:52:30

Tags for this article:

Click the tags to see associated articles and topics

Israeli startup CytoReason joins forces with Ferring Pharmaceuticals to find new IBD treatment. View article details on hiswai:

Excerpt

French AI startup Iktos recently announced it is collaborating with drug ... Iktos has also previously partnered with Germany science and technology ...

Article found on: www.mobihealthnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up